These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6841013)

  • 21. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
    Robison WG; Kador PF; Kinoshita JH
    Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of aldose reductase gene expression in renal cortex and medulla of rats.
    Dorin RI; Shah VO; Kaplan DL; Vela BS; Zager PG
    Diabetologia; 1995 Jan; 38(1):46-54. PubMed ID: 7744229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defensive role of quercetin against imbalances of calcium, sodium, and potassium in galactosemic cataract.
    Ramana BV; Raju TN; Kumar VV; Reddy PU
    Biol Trace Elem Res; 2007 Oct; 119(1):35-41. PubMed ID: 17914217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil.
    Nagaraj RH; Monnier VM
    Exp Eye Res; 1990 Oct; 51(4):411-8. PubMed ID: 2120080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nonenzymatic glycosylation in experimental cataract formation.
    Chiou SH; Chylack LT; Bunn HF; Kinoshita JH
    Biochem Biophys Res Commun; 1980 Jul; 95(2):894-901. PubMed ID: 7417294
    [No Abstract]   [Full Text] [Related]  

  • 27. Corneal re-epithelialization in galactosemic rats.
    Datiles MB; Kador PF; Fukui HN; Hu TS; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):563-9. PubMed ID: 6841002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of aging on the development of rat galactosemic cataract].
    Ikebe H; Terubayashi H; Tsutsumi M; Mori K; Akagi Y; Kawasaki N; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1991 Jun; 95(6):538-42. PubMed ID: 1897453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosemia. Relationship to pentosidine cross-links.
    Richard S; Tamas C; Sell DR; Monnier VM
    Diabetes; 1991 Aug; 40(8):1049-56. PubMed ID: 1907247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical aspirin provides protection against galactosemic cataract.
    Gupta SK; Joshi S; Tandon R; Mathur P
    Indian J Ophthalmol; 1997 Dec; 45(4):221-5. PubMed ID: 9567017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of galactosemic-induced inhibition of PGH synthase activity in cultured lens epithelial cells.
    Cammarata PR; Jackson T; Lou M; Yorio T
    Curr Eye Res; 1989 Oct; 8(10):1063-9. PubMed ID: 2515034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Sato S; Wyman M
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytological aspects of sugar-induced cataract formation].
    Kamiya M; Majima Y; Iwata S
    Nippon Ganka Gakkai Zasshi; 1988 Feb; 92(2):262-8. PubMed ID: 3133931
    [No Abstract]   [Full Text] [Related]  

  • 37. Galactose neuropathy. Structural changes evaluated by nuclear magnetic resonance spectroscopy.
    Griffey RH; Eaton RP; Gasparovic C; Sibbitt W
    Diabetes; 1987 Jun; 36(6):776-8. PubMed ID: 3032717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osmoregulatory alterations in taurine uptake by cultured human and bovine lens epithelial cells.
    Cammarata PR; Schafer G; Chen SW; Guo Z; Reeves RE
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):425-33. PubMed ID: 11818387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmoscopic and morphogenetic changes in rat lens induced by galactose: attenuation by pyruvate.
    Kalakonda S; Hegde KR; Varma SD
    Diabetes Obes Metab; 2004 May; 6(3):216-22. PubMed ID: 15056130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.